ÍøÆØÃÅ

Deep cuts to federal research funding and crackdowns on international students could mean far fewer graduate students next fall and beyond. If that happens, undergraduates, faculty and research productivity would all suffer.

Some community colleges have stripped back DEI programming and made other cuts under federal and state pressures.

With US academia under siege from the Trump administration, universities elsewhere are contemplating offering ¡®asylum¡¯ to disaffected researchers. Here, four former US academics now established abroad reflect on the potential culture shock that awaits US ¨¦migr¨¦s

The Trump administration specifically targeted a department at Columbia, prompting a sweeping review. Harvard is shaking up and pausing programs. It¡¯s unclear what¡ªand where¡ªthe next target will be.

Data indicates more scholars turning to alternative social media site to post about their work after Elon Musk¡¯s Twitter takeover

Immigration officials are rapidly revoking hundreds of student visas. Many more are going unreported at small colleges anxious to avoid federal scrutiny.

Institutions scramble to quell ¡®panic¡¯ caused by visa revocations, while seeking to avoid incurring wrath of regime intent on cutting funding

New College of Florida may soon take over stewardship of a local art museum and another branch campus. Critics argue NCF doesn¡¯t have the means or capability to manage either.

From lawsuits to protests, labor organizations representing faculty, grad students and other workers are resisting. Discussions about what to do next continue.

Trump¡¯s attacks are not the only problem: falling enrolment and birth rates are forcing colleges to be more things to more people, says Kathleen deLaski 

Exactly how many staff members and grants will be slashed from the National Endowment for the Humanities remains unclear, but prior cuts at the Education Department and National Institutes of Health offer a grim forecast.

The National Institutes of Health terminated numerous federal research grants that officials say no longer align with the agency¡¯s priorities. But experts see multiple avenues to appeal the NIH¡¯s decisions.